Sesame's weight-management page displays milestone language alongside its subscription offer. The page attributes those milestones to a semaglutide study under specified conditions. That attribution should remain visible: the graphic is not, by itself, an independent report of results among Sesame subscribers.
Follow the study before accepting the shorthand
Identify the medicine, participants, accompanying care and period observed. Then ask whether the advertised treatment you are considering matches that setting. The claim-transfer guide explains why an ingredient name cannot bridge every difference.
Our desk has not measured Sesame patient outcomes or compared its individual providers. Testimonials and platform ratings are not used here as substitutes for a controlled clinical comparison.
Read the subscription as a separate offer
The official starting care fee is $59 monthly with a twelve-month commitment. The monthly option is $99, and individual providers may charge more. Medication is excluded from the subscription. These terms establish a commercial access structure, not the likelihood of reaching a displayed milestone.
Sesame describes video visits, messaging and a choice of provider. Confirm the selected clinician's arrangements and the actual amount due before enrolling. Medicine coverage and clinical suitability remain separate decisions.
Keep the conclusion limited to the evidence
This profile can describe the public offer and identify the source type behind a marketing claim. It cannot validate a service-level outcome from a medicine trial alone. Read the abstract note if the underlying publication is available only as a short summary, and retain the unreviewed details as open questions.
Source notes
Checked October 5, 2026. Provider pages document advertised terms. Study summaries identify the scope of our review.
- Online weight loss medication with or without insuranceProvider public offer; checked October 5, 2026